| |
NAFLD |
Control |
P value |
| n |
53 |
45 |
|
| Age (y) |
58.8±5.9 |
56.2±6.1 |
0.212 |
| Sex (female/male) |
32/21 |
26/19 |
0.399 |
| BMI (kg/m2) |
32.0±4.1 |
32.8±3.0 |
0.402 |
| ALT (IU/L) |
44.1±28.7 |
23.0± 3.1 |
<0.001 |
| AST (IU/L) |
37.6±19.6 |
22.0±3.3 |
<0.001 |
| FG (mg/dL) |
90.3±9.0 |
87.1±7.0 |
0.098 |
| TG (mg/dL) |
188.7±88.6 |
187.1±25.8 |
0.111 |
| T.Chol (mg/dL) |
199.5±30.4 |
190.2±12.7 |
0.127 |
| HDL-C (mg/dL) |
42.6±10.0 |
40.6±4.6 |
0.198 |
| LDL-C (mg/dL) |
119.5±23.5 |
112.3±11.5 |
0.101 |
|
| NAFLD: Non Alcoholic Fatty Liver Disease; BMI: Body Mass Index; ALT: Alanineaminotransferase; AST: Aspartate aminotransferase; FPG: Fasting Plasma Glucose; TG: Triglyceride; T.Chol: Total Cholesterol; HDL-C: High Density Lipoprotein Cholesterol; LDL-C: Low Density Lipoprotein Cholesterol |
| Table 1: Clinical and biochemical characteristic of patients with NAFLD and control subjects. Results were presented as mean ± SD. |
